Private Equity Deals, British Columbia, Biotech and Life Sciences, IT and Telecom, United States
Insight’s Insightful Science acquires Cytapex Bioinformatics
Venture Capital Deals, British Columbia, Biotech and Life Sciences
AbCellera secures US $105M Series B following $175.6M government funding
Private Equity Deals, Biotech and Life Sciences, Public Deals, Ontario, United States
VBI Vaccines secures US $50M debt financing from K2 HealthVentures
Venture Capital Deals, British Columbia, Biotech and Life Sciences
ARTMS secures US $19M Series A led by Deerfield
Venture Capital Deals, Biotech and Life Sciences, Ontario
TIAP, Evotec, AmorChem invest $1.75M in Netherton Syndrome project
Venture Capital Deals, Biotech and Life Sciences, Quebec, United States
Ventus Therapeutics launches with US $60M from Versant Ventures and GV
British Columbia, Biotech and Life Sciences, Government Funding
DCVC Bio backed AbCellera secures $175.6M government commitment to develop antibodies
Venture Capital Deals, Biotech and Life Sciences, Nova Scotia
Fonds de Solidarité and Lumira to co-lead IMV’s CDN $22.3M private placement
Alberta, Biotech and Life Sciences, M&A/Exit Deals
OncoQuest to sell immunotherapy development assets to Dual Industrial for US $300M
Venture Capital Deals, Biotech and Life Sciences, HealthCare, Ontario
CleanSlate UV secures US $7M Series A led by Prolog Ventures
Venture Capital Deals, Biotech and Life Sciences, Ontario
Zucara Therapeutics secures US $21M Series A led by Perceptive Xontogeny Venture Fund
Private Equity Deals, Biotech and Life Sciences, Quebec, Europe
Ampersand Capital Partners’ Nexelis to acquire ImmunXperts
VC Funds, Biotech and Life Sciences, Quebec, Europe
Fonds de solidarité commits €5M to €38M Theodorus IV
Venture Capital Deals, Biotech and Life Sciences, Ontario, IT and Telecom
BenchSci secures US $22M Series B led by F-Prime Capital
Biotech and Life Sciences, IPO, RTO Deals, United States
Versant Ventures backed Black Diamond Therapeutics closes US $201M IPO